Dr. Reddys Laboratories Ltd.

BSE: 500124 | NSE: DRREDDY
Large Cap | Pharmaceuticals & Drugs
1175.55
-10.90 (-0.92%)
< Home < Back

Dr. Reddy's Lab - Quaterly Results

Date: 28-07-2022
The company witnessed a 5.74% growth in the revenue at Rs. 36306.00 millions for the quarter ended June 2022 as compared to Rs. 34335.00 millions during the year-ago period.Profit saw a slight increase of 20.83%to Rs. 4995.00  millions from Rs. 4134.00 millions.Operating profit for the quarter ended June 2022 rose to 9829.00 millions as compared to 7481.00 millions of corresponding quarter ended June 2021.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202206 202106 % Var 202206 202106 % Var 202203 202103 % Var
Sales 36306.00 34335.00 5.74 36306.00 34335.00 5.74 144052.00 133491.00 7.91
Other Income 4034.00 1862.00 116.65 4034.00 1862.00 116.65 4820.00 8011.00 -39.83
PBIDT 9829.00 7481.00 31.39 9829.00 7481.00 31.39 30761.00 39379.00 -21.88
Interest 98.00 65.00 50.77 98.00 65.00 50.77 380.00 467.00 -18.63
PBDT 9731.00 7416.00 31.22 9731.00 7416.00 31.22 30381.00 38912.00 -21.92
Depreciation 2215.00 1971.00 12.38 2215.00 1971.00 12.38 8143.00 8350.00 -2.48
PBT 7516.00 5445.00 38.03 7516.00 5445.00 38.03 22238.00 30562.00 -27.24
TAX 2521.00 1311.00 92.30 2521.00 1311.00 92.30 6006.00 8698.00 -30.95
Deferred Tax 1163.00 327.00 255.66 1163.00 327.00 255.66 2080.00 3297.00 -36.91
PAT 4995.00 4134.00 20.83 4995.00 4134.00 20.83 16232.00 21864.00 -25.76
Equity 832.00 832.00 0.00 832.00 832.00 0.00 832.00 832.00 0.00
PBIDTM(%) 27.07 21.79 24.25 27.07 21.79 24.25 21.35 29.50 -27.61